secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001022079-26-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q4 rev $2.81B (+7.1%), adj EPS $2.42 (+8.5%); raises dividend 7.5%
--------------------------------------------------------------------------------

- FY2025 revenue $11.04B (+11.8%), reported EPS $8.75 (+13.8%), adjusted EPS $9.85 (+10.3%).
- Q4 organic requisition volume +7.9%; operating cash flow $465M; FY cash from ops $1.89B.
- FY2026 guidance: revenue $11.70B-$11.82B, adjusted EPS $10.50-$10.70.
- Quarterly dividend raised 7.5% to $0.86/share, payable Apr 20, 2026 to holders of record Apr 6, 2026.
- Board authorized additional $1B share repurchase; $0.4B remained from prior program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207926000005/0001022079-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207926000005/dgx-20260210.htm
  HTML page:      https://secwatch.observer/filing/0001022079-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer